Big Pharma Enters The Psychedelic Space Beyond Partnerships As Otsuka Acquires Mindset Pharma Aug 31, 2023
Mindset Pharma: Psilocybin-Like Compound MSP-1014 Advancing Towards Phase 1 Clinical Trials Jun 29, 2022
Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application Covering its Next-Generation DMT… Apr 19, 2022
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with… Feb 17, 2022
Mindset Pharma Appoints Dr. Fiona Randall as Senior Vice President of External Alliances and Scientific Strategy Feb 8, 2022
Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying Cognitive Benefits of its “Microdosing”… Feb 3, 2022
